Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.
Gaudio
Agostino
A
Department of Internal Medicine, University of Catania, 95124 Catania, Italy.
Pennisi
Pietra
P
Bratengeier
Cornelia
C
Torrisi
Venerando
V
Lindner
Brigitte
B
Mangiafico
Roberto A
RA
Pulvirenti
Ivana
I
Hawa
Gerhard
G
Tringali
Giovanni
G
Fiore
Carmelo E
CE
D048868:Adaptor Proteins, Signal Transducing; D000368:Aged; D000369:Aged, 80 and over; D015992:Body Mass Index; D001846:Bone Development / Q000502:physiology*; D019485:Bone Morphogenetic Proteins / Q000097:blood*; D001862:Bone Resorption / Q000209:etiology*; D003327:Coronary Disease / Q000453:epidemiology; D003430:Cross-Sectional Studies; D003863:Depression / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000453:epidemiology; D005260:Female; D005819:Genetic Markers; D006801:Humans; D007103:Immobilization / Q000009:adverse effects*; D010006:Osteoblasts / Q000502:physiology; D010011:Osteocytes / Q000502:physiology; D010291:Paresis / Q000209:etiology; D017698:Postmenopause; D012016:Reference Values; D020521:Stroke / Q000097:blood / Q000150:complications / Q000503:physiopathology
D048868:Adaptor Proteins, Signal Transducing; D019485:Bone Morphogenetic Proteins; D005819:Genetic Markers; C422903:SOST protein, human